Albany, NY -- (SBWIRE) -- 02/10/2017 -- The growing number of cancer patients across the globe is propelling the demand for cell counting products. Cell counting products such as cell counters, flow cytometers, hematology analyzers, and spectrophotometers are used extensively by research institutions, hospitals, and pharmaceutical companies. Cell counting proves to be an important step in various experimental workflows by researchers to help them maintain cell cultures and prepare cells for transfection and downstream experiments.
The global cell counting market is segmented on the basis of product, end user, and geography. By end user, the market is segmented into research institutions, hospitals, diagnostic laboratories, biotechnology companies, and pharmaceutical companies. On the basis of product, the global cell counting market is segmented into instruments and consumables and accessories. The consumables and accessories segment is further categorized into reagents, assay kits, accessories, microplates, and others. Further, the instruments segment is categorized into spectrometers, flow cytometers, hematology analyzers, and cell counters.
The report on the global cell counting market comprises value chain and stakeholder analysis, supply and demand analysis, and the competitive landscape. The report gives the current, historical, and future size of the market in terms of volume and value. The market shares of key vendors and strategies implemented by them to grow in the market have been evaluated in detail. The assessment of the trajectory of the market and emerging opportunities and trends are also included in the report.
Download Exclusive Brochure of This Report: https://goo.gl/ZjOo8K
Overview of the Cell Counting Market by Product
The high prevalence of cancer and AIDS across the globe has led to a surge in the global demand for cell counting products. The introduction of enhanced data visualization and analysis software is encouraging the market's growth. The increasing expenditure on stem cell research has given a rise to the demand for cell counting products. Moreover, government support and participation through funding is also driving the adoption of cell counting products worldwide. On the other hand, the lack of proper research and healthcare infrastructure, especially in emerging economies, is limiting the growth of the market. The lack of skilled professionals and the high cost of cell counting products are other restraining factors impacting the growth of the market.
On the basis of geography, the global cell counting market is segmented into Asia Pacific, North America, Europe, and the Rest of the World. Of these, North America and Europe are currently leading in the market by revenue. The prominence of cell counting product manufacturers in these regions is the major reason behind the growth of the market in North America and Europe. Other factors contributing to the growth of the market include an increasing number of cell-based and stem cell research programs initiated by the government and the presence of highly developed healthcare systems.
Asia Pacific is projected to be the fastest growing region in the coming years owing to a rise in research collaboration, growing geriatric population, and the expanding healthcare sector. The rising focus of leading companies on Asia Pacific countries and the growing demand for cutting-edge technology are also behind the region's significant growth. Other factors driving the demand for cell counting products in Asia Pacific include the rapid expansion of private sector hospitals in rural areas and the increasing expenditure on R&D.
Companies Mentioned in the Report
Key companies operating in the global cell counting market have been profiled in the report. They are: Thermo Fisher Scientific Inc., GE Healthcare, Tecan Group Ltd., PerkinElmer Inc., Biotek Instruments Inc., Becton, Dickinson, and Company, Bio-Rad Laboratories Inc., Danaher Corporation, Merck Millipore, and Agilent Technologies Inc.
Browse Global Strategic Business Report: https://goo.gl/KrR28a